Welcome to the Sanofi Media Room

Our Media Room is designed to provide reporters with company and product news, as well as key facts, figures and background information.  To help you keep up with the latest news, we offer email alerts and RSS feeds.  If you are a reporter and have questions about the company or our products, visit the Media Contacts page.

Press Releases
May 4, 2026
Sanofi invests $294M to expand AI Center of Excellence in Toronto and accelerate innovation for patients

Expansion to create 50 new high-skilled jobs in AI and reinforce Sanofi's long-term commitment to Ontario Invest Ontario Fund to contribute a conditional grant of up to $5 million Partnership with...

Apr 9, 2026
Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians

Nuvaxovid, a non-mRNA COVID-19 vaccine, will be made available in Canada by Sanofi for the fall 2026-2027 season Provincial and territorial availability will be confirmed pending ongoing...

Feb 3, 2026
Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease (GVHD)

Three provinces now cover Rezurock® (belumosudil) through their provincial formularies for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (GVHD) after...

More »

Stay Updated
* Required Fields